Law360, New York (February 26, 2008, 12:00 AM EST) -- Marking a sweeping victory for AstraZeneca, a federal judge ruled Monday that a group of drugstores had failed to prove the pharmaceutical giant violated antitrust law when it put its marketing muscle behind heartburn drug Nexium instead of Prilosec as the latter's patent protection was about to lapse.
Judge Richard W. Roberts of the U.S. District Court for the District of Columbia granted AstraZeneca's motions to dismiss the complaints.
“Plaintiffs have not alleged facts that support an inference that AstraZeneca’s conduct in switching the market from...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.